The North America Protein Engineering Market would witness market growth of 15.5% CAGR during the forecast period (2024-2031).
The US market dominated the North America Protein Engineering Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $2,147.9 million by 2031. The Canada market is experiencing a CAGR of 18.1% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 17.1% during (2024 - 2031).
The market has become a highly dynamic and swiftly developing sector in the biotechnology industry, influencing numerous fields such as agriculture, industrial biotechnology, healthcare, and environmental science. This transformative field leverages the principles of molecular biology, genetic engineering, and bioinformatics to design and construct novel proteins or modify existing ones with enhanced or entirely new functions.
Protein engineering involves modifying protein structures to improve their properties or endow them with new capabilities. Proteins, the fundamental building blocks of life, perform myriad functions within biological systems, from catalyzing metabolic reactions as enzymes to serving as structural components and signaling molecules. The capacity to precisely engineer these molecules presents an abundance of prospects for the advancement of novel therapeutics, industrial enzymes, biosensors, and additional applications.
In Mexico, the demand for this engineering is driven by factors such as a growing pharmaceutical industry and increasing investment in research and development. According to the Mexican Association of Pharmaceutical Research Industries (AMIIF), the pharmaceutical sector in Mexico has been growing steadily. This growth is partly fueled by increasing investment in research and development, which drives demand for engineering technologies and expertise. Consequently, these factors create significant market opportunities for engineering technologies and products, leading to continued growth and innovation.
Free Valuable Insights: The Protein Engineering Market is Predict to reach USD 7.8 Billion by 2031, at a CAGR of 16.0%
Based on Product, the market is segmented into Instruments, Reagents, and Software & Services. Based on End-use, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) and Academic Research Institutes. Based on Technology, the market is segmented into Rational Protein Design, Hybrid Approach, Directed Evolution, De Novo Protein Design, and Others. Based on Protein Type, the market is segmented into Monoclonal Antibodies, Insulin, Vaccines, Growth Factors, Interferon, Colony Stimulating Factors, Coagulation Factors, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
By Product
By End-use
By Technology
By Protein Type
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 